...
首页> 外文期刊>European Journal of Surgical Oncology: The Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology >A comparison of right and extended right hepatectomy with all other hepatic resections for colorectal liver metastases: a ten-year study.
【24h】

A comparison of right and extended right hepatectomy with all other hepatic resections for colorectal liver metastases: a ten-year study.

机译:一项针对大肠肝转移的右,大面积右肝切除术与所有其他肝切除术的比较:一项为期十年的研究。

获取原文
获取原文并翻译 | 示例
           

摘要

AIMS: Colorectal liver metastases are treated by a combination of adjuvant chemotherapy followed by liver resection. In this study we compared all major right-sided resections with left or parenchymal sparing resections. METHODS: Consecutive patients (n=283) who had successful hepatic resections for colorectal metastases from September 1996 to November 2006 were prospectively studied. Early and late outcomes of those who had right and extended right hepatectomies (RH) were compared with those who had all other types of liver resection (AOLR). Adjuvant therapy and pre-operative assessment were standardised for all. RESULTS: The 1-, 3- and 5-year overall survival rates in the RH group were 84.1%, 54.3% and 38.9%, respectively. The 1-, 3- and 5-year overall survival rates in the AOLR group were 95.4%, 65.9% and 53.3%, respectively. The difference was statistically significant (p=0.03). The 1-, 3- and 5-year disease-free survival rates in the RH group were 69.5%, 34.4% and 25.5%, respectively and 68.4%, 34.91% and 34.91%, respectively in the AOLR group (p=0.46). Operative mortality was 3.9% in the RH group and 0.7% in the AOLR group (p=0.04). Morbidity was 31.3% in the RH group and 18% in the AOLR group. CONCLUSION: Patients undergoing right and extended right hepatectomies for colorectal metastases have a greater operative morbidity and mortality and have a significantly worse overall survival compared to all other liver resections for the same disease.
机译:目的:通过辅助化疗联合肝切除术治疗结直肠肝转移。在这项研究中,我们将所有主要的右侧切除与左侧或实质保留切除进行了比较。方法:前瞻性研究了1996年9月至2006年11月成功切除大肠转移灶的连续患者(n = 283)。将具有正确和扩展的右肝切除术(RH)的患者的早期和晚期结果与进行所有其他类型肝切除术(AOLR)的患者进行比较。所有患者的辅助治疗和术前评估均已标准化。结果:RH组的1年,3年和5年总生存率分别为84.1%,54.3%和38.9%。 AOLR组的1年,3年和5年总生存率分别为95.4%,65.9%和53.3%。差异具有统计学意义(p = 0.03)。 RH组的1年,3年和5年无病生存率分别为AOLR组的69.5%,34.4%和25.5%以及AOLR组的68.4%,34.91%和34.91%(p = 0.46) 。 RH组的手术死亡率为3.9%,AOLR组的手术死亡率为0.7%(p = 0.04)。 RH组的发病率为31.3%,AOLR组的发病率为18%。结论:与同种疾病的所有其他肝切除术相比,接受右肝切除术和右肝切除术治疗结直肠癌转移的患者具有更高的手术发病率和死亡率,并且其总生存率显着降低。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号